NDAVAGINALINSERT
Approved
Jun 2007
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
20
Data completeness
5/8 — Partial
ENDOMETRIN (progesterone) by Ferring Pharmaceuticals. Approved for progesterone [epc]. First approved in 2007.
Drug data last refreshed 8h ago · AI intelligence enriched 11h ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
ENDOMETRIN is a vaginal progesterone insert approved in 2007 for hormone replacement and reproductive health support. It delivers progesterone directly to the endometrium via a novel vaginal insert formulation. The drug is used primarily in fertility and reproductive medicine to support luteal phase adequacy.
$0.008BPart D
LOE ApproachingDeclining
Product approaching loss of exclusivity with minimal Part D claims suggests a niche, mature market with limited growth opportunities and smaller brand team requirements.
Mechanism of Action
Pharmacologic Class:
Progesterone
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (20)
Individualized Prolonged Luteal Support After Fresh Embryo Transfer in Women With Low Progesterone
Started Mar 2027
214 enrolled
PregnancyProgesterone SupplementationLow Serum Progesterone
Cycle-to-cycle Variability of Progesterone in the Endometrium in Patients Undergoing an Euploid Blastocyst Transfer in a Hormone Replacement Therapy (HRT) Cycle (PROMICOFET)
Started Oct 2026
70 enrolled
FertilityImplantation, Embryo
Comparing the Pharmacokinetics of a Progesterone Ring Versus a Progesterone Vaginal Insert
Started Sep 2026
60 enrolled
Pre Term Birth
Exogenous Progesterone as Ovulation Trigger
Started Jul 2026
10 enrolled
OvulationOvarian FunctionAssisted Reproductive Treatments+2 more
Comparison of Two Vaginal Progesterone Forms in Frozen Embryo Transfer
Started Nov 2024
400 enrolled
Frozen Embryo Transfer (FET)InfertilityArtificial Cycle+1 more
Worked on ENDOMETRIN at Ferring Pharmaceuticals? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.